Interestingly, Focke et al. [13], found that heterogenous PI in early-stage breast cancer exceeded the variability between individual tumors, and Stålhammer et al. [28] concluded that Ki-67 hot spots should be the best marker for proliferation in breast cancer. This evidence concerns the gene MKI67 and breast cancer.